Cargando…
Correction: Abdulle, A.E., et al. Hydrogen Sulfide: A Therapeutic Option in Systemic Sclerosis. Int. J. Mol. Sci. 2018, 19, 4121
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6887776/ https://www.ncbi.nlm.nih.gov/pubmed/31726735 http://dx.doi.org/10.3390/ijms20225663 |
_version_ | 1783475087747317760 |
---|---|
author | Abdulle, Amaal Eman van Goor, Harry Mulder, Douwe J. |
author_facet | Abdulle, Amaal Eman van Goor, Harry Mulder, Douwe J. |
author_sort | Abdulle, Amaal Eman |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-6887776 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-68877762019-12-09 Correction: Abdulle, A.E., et al. Hydrogen Sulfide: A Therapeutic Option in Systemic Sclerosis. Int. J. Mol. Sci. 2018, 19, 4121 Abdulle, Amaal Eman van Goor, Harry Mulder, Douwe J. Int J Mol Sci Correction MDPI 2019-11-12 /pmc/articles/PMC6887776/ /pubmed/31726735 http://dx.doi.org/10.3390/ijms20225663 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Correction Abdulle, Amaal Eman van Goor, Harry Mulder, Douwe J. Correction: Abdulle, A.E., et al. Hydrogen Sulfide: A Therapeutic Option in Systemic Sclerosis. Int. J. Mol. Sci. 2018, 19, 4121 |
title | Correction: Abdulle, A.E., et al. Hydrogen Sulfide: A Therapeutic Option in Systemic Sclerosis. Int. J. Mol. Sci. 2018, 19, 4121 |
title_full | Correction: Abdulle, A.E., et al. Hydrogen Sulfide: A Therapeutic Option in Systemic Sclerosis. Int. J. Mol. Sci. 2018, 19, 4121 |
title_fullStr | Correction: Abdulle, A.E., et al. Hydrogen Sulfide: A Therapeutic Option in Systemic Sclerosis. Int. J. Mol. Sci. 2018, 19, 4121 |
title_full_unstemmed | Correction: Abdulle, A.E., et al. Hydrogen Sulfide: A Therapeutic Option in Systemic Sclerosis. Int. J. Mol. Sci. 2018, 19, 4121 |
title_short | Correction: Abdulle, A.E., et al. Hydrogen Sulfide: A Therapeutic Option in Systemic Sclerosis. Int. J. Mol. Sci. 2018, 19, 4121 |
title_sort | correction: abdulle, a.e., et al. hydrogen sulfide: a therapeutic option in systemic sclerosis. int. j. mol. sci. 2018, 19, 4121 |
topic | Correction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6887776/ https://www.ncbi.nlm.nih.gov/pubmed/31726735 http://dx.doi.org/10.3390/ijms20225663 |
work_keys_str_mv | AT abdulleamaaleman correctionabdulleaeetalhydrogensulfideatherapeuticoptioninsystemicsclerosisintjmolsci2018194121 AT vangoorharry correctionabdulleaeetalhydrogensulfideatherapeuticoptioninsystemicsclerosisintjmolsci2018194121 AT mulderdouwej correctionabdulleaeetalhydrogensulfideatherapeuticoptioninsystemicsclerosisintjmolsci2018194121 |